Close Menu

NEW YORK (GenomeWeb) – Cytox announced today that it and Cardiff University have been awarded an £800,000 ($1.1 million) grant from Innovate UK to test and validate the clinical utility of the British company's SNP-based risk assessment panel for Alzheimer's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.